Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys) or Recombinant Interferon Alfa-2a (Roferon-A) in Prior Clinical Studies
Conditions:   Chronic Myelogenous Leukemia;   Malignant Melanoma;   Renal Cell CarcinomaInterventions:   Drug: Pegylated Interferon Alfa-2a;   Drug: Recombinant Interferon Alfa 2aSponsor:   Hoffmann-La RocheCompleted - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2016 Category: Research Source Type: clinical trials

A Study of Continued Treatment Among Participants Who Have Responded to Peginterferon Alfa-2a (Pegasys) or Recombinant Interferon Alfa-2a (Roferon-A) in Prior Clinical Studies
< b > Conditions < /b > :   Chronic Myelogenous Leukemia;   Malignant Melanoma;   Renal Cell Carcinoma < br/ > < b > Interventions < /b > :   Drug: Pegylated Interferon Alfa-2a;   Drug: Recombinant Interferon Alfa 2a < br/ > < b > Sponsor < /b > :   Hoffmann-La Roche < br/ > < b > Completed < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2016 Category: Research Source Type: clinical trials